<?xml version="1.0" encoding="UTF-8"?>
<p>Passive antibody administration conferring rapid immunity through humoral mechanisms (e.g., Anthrax vaccination), regardless of the immunity level of the individual, has been proposed as a specific defense against biological weapons and would be useful to health care workers, first responders, and military personnel who are at risk for exposure to biological weapons (Casadevall, 
 <xref ref-type="bibr" rid="CR2_7">2002</xref>). However, the cost of the development and administration of such vaccinations is questionable if readily available drug therapy is available.
</p>
